Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Retailer executions leading up to the Super Bowl were the most aggressive in years,” reports trade magazine Beer Business ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Even with the increased overlap from digital transformation, understanding the distinction between marketing and advertising ...

The unveiling of the 23rd edition of the comprehensive report will be held in Mumbai in presence of industry titans and other ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

NoticeAds.in, a part of the Riyo Advertising Group, is redefining public notice publishing by providing a seamless, ...

According to the Pitch Madison Advertising Report (PMAR) released today, the country's AdEx is projected to reach Rs 1.2 lakh ...

Ad revenue growth is estimated to slow down to 7 per cent in 2025 from the 8.8 per cent attained in 2024, a leading media ...

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.

TV, digital and print ads seek to build support after the Texas Senate approved Senate Bill 2’s voucher-style plan.

Editors and publishers of several independent news outlets in Connecticut have submitted testimony in favor of a bill that ...